Publication:
Discovery and evaluation of novel pyrrole/thiophene chalcone urea EGFR inhibitors via biological and docking studies.

dc.contributor.authorZengin Kurt B.
dc.contributor.authorÖztürk Civelek D.
dc.contributor.authorŞahin Bektay H.
dc.contributor.authorÖzbilge Ulueren A.
dc.contributor.authorKolcuoğlu Y.
dc.contributor.authorAkdemir A.
dc.contributor.authorŞahin A. F.
dc.contributor.authorDurukan Z.
dc.contributor.authorSönmez F.
dc.date.accessioned2025-07-17T21:50:20Z
dc.date.issued2025-06-30
dc.identifier.citationZengin Kurt B., Öztürk Civelek D., Şahin Bektay H., Özbilge Ulueren A., Kolcuoğlu Y., Akdemir A., Şahin A. F., Durukan Z., Sönmez F., "Discovery and evaluation of novel pyrrole/thiophene chalcone urea EGFR inhibitors via biological and docking studies.", Future medicinal chemistry, ss.1-16, 2025
dc.identifier.doi10.1080/17568919.2025.2521249
dc.identifier.issn1756-8919
dc.identifier.pubmed40583623
dc.identifier.urihttps://hdl.handle.net/20.500.12645/40804
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleDiscovery and evaluation of novel pyrrole/thiophene chalcone urea EGFR inhibitors via biological and docking studies.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id0078c219-f03e-433d-9451-8b5e34e65335

Files